Newsletter | January 27, 2026

01.27.26 -- STREAM Edition: Advancing Off-The-Shelf CRISPR CAR-T Therapies Into The Community Setting With Caribou Biosciences' Rachel Haurwitz

The Importance Of Potency Assays

Video | Cell & Gene

Hear from Kathryn Golden, the SVP Technical Operations & Cell Manufacturing at bit.bio, on the importance of potency assays.

A 3rd Generation Filling System

Video | Invetech

Explore this 3rd Generation Filling System, an automated bag filling platform for GMP manufacturing.

Enhancing AAV Purification In Gene Therapy Manufacturing

Webinar | Thermo Fisher Scientific Bioproduction

Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.

 

Path To IND: AAV Transient Transfection, Producer Cell Line Platforms

Webinar | Lonza

Discover how to overcome AAV manufacturing hurdles with high-titer transfection, stable cell lines, and higher capsid quality.

A Concept-To-Commercial Gene Therapy CDMO

Video | Andelyn Biosciences

See how data from this platform were used to manufacture more than 450 Phase 1 and 2 clinical batches, spanning over 17 years.

Advancing Off-The-Shelf CRISPR CAR-T Therapies Into The Community Setting With Caribou Biosciences' Rachel Haurwitz

Video | Cell & Gene

On episode 120 of Cell & Gene: The Podcast, Host Erin Harris is joined by Rachel Haurwitz, CEO of Caribou Biosciences, to discuss the company’s progress in developing CRISPR-edited, off-the-shelf CAR-T therapies for hematologic malignancies.